Jin Medical (NASDAQ: ZJYL) sets fireside chat to discuss growth plans

Rhea-AI Filing Summary

Jin Medical International Ltd. filed a Form 6-K to share a press release about an upcoming management fireside chat and an updated corporate website. The fireside chat, led by the CEO and management team, will be webcast at 8:00 pm EST on February 1, 2026 via the company’s site.

The discussion is expected to cover the company’s recent strategic priorities and long-term growth considerations. Jin Medical, a China-based provider of rehabilitation medical equipment, highlights its wheelchair and living aids business, multiple manufacturing plants, expanding production footprint, and distribution network in China, Japan, and other international markets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Accepted by SEC EDGAR 01/28/2026 - 08:00 AM Learn about SEC filing dates

FAQ

What did Jin Medical International Ltd. (ZJYL) disclose in its latest Form 6-K?

Jin Medical International Ltd. disclosed a press release announcing a management fireside chat and the launch of its updated corporate website. The filing highlights plans to discuss strategic priorities and long-term growth, and notes that the event will be webcast through the company’s new site.

When will Jin Medical (ZJYL) host its management fireside chat and what will it cover?

Jin Medical will host its management fireside chat at 8:00 pm EST on February 1, 2026. The CEO and management team plan to discuss recent strategic priorities and long-term growth considerations, providing investors and stakeholders with broader insight into the company’s direction.

How can investors access Jin Medical International Ltd.’s upcoming fireside chat?

Investors can access Jin Medical’s fireside chat via a webcast on its updated corporate website at http://www.jinmed.com. The event, led by the CEO and management team, is scheduled for 8:00 pm EST on February 1, 2026 and will focus on strategy and growth.

What business does Jin Medical International Ltd. (ZJYL) operate in?

Jin Medical operates in the rehabilitation medical equipment sector, designing and manufacturing wheelchairs and living aids. The company serves people with disabilities and the elderly, runs multiple plants in China, and sells more than 30 wheelchair models mainly through distributors in Japan and China.

Where are Jin Medical International Ltd.’s main manufacturing facilities located?

Jin Medical’s main manufacturing plants are in Changzhou City and Taizhou City, Jiangsu Province, China, totaling about 230,000 square feet. It is also establishing a new 430,000 square foot facility in Chuzhou, Anhui Province to expand production capacity for its rehabilitation equipment products.

How extensive is Jin Medical (ZJYL)’s distribution network for its wheelchair products?

Jin Medical works with more than 40 distributors in China and over 20 international distributors. The majority of its wheelchair products, which include more than 30 models, are sold to distributors primarily in Japan and China, supporting its position in rehabilitation medical equipment markets.

Does Jin Medical’s press release include any forward-looking statements or risks?

Yes. The press release includes forward-looking statements about goals, strategies, business development and financial conditions, subject to risks and uncertainties. It cites factors like competition, regulations, economic conditions and other risks discussed in the company’s SEC filings, cautioning investors against undue reliance on such statements.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2026

Commission File Number: 001-41661

Jin Medical International Ltd.

(Exact name of registrant as specified in its charter)

No. 33 Lingxiang Road, Wujin District

Changzhou City, Jiangsu Province

People’s Republic of China

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Press Release

On January 26, 2026, the Company published a press release entitled “Jin Medical International Ltd. To Host Management Fireside Chat”, a copy of which is attached hereto as Exhibit 99.1.

The information in the press release furnished in Exhibit 99.1 hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Furthermore, the information in the press release shall not be deemed to be incorporated by reference in the filings of the Company under the Securities Act of 1933, as amended, except in the event that the Company expressly states that such information is to be considered filed under the Exchange Act or incorporates it by specific reference in such filing.

1

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press Release dated January 26, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Jin Medical International Ltd.
Date: January 28, 2026	By:	/s/ Erqi Wang
		Erqi Wang
		Chief Executive Officer

3

Exhibit 99.1

Jin Medical International Ltd. To Host Management Fireside Chat

CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that its Chief Executive Officer, together with the Company’s management team, will host a fireside chat at 8:00 pm EST on February 1, 2026. The discussion will provide insights into the Company’s recent strategic priorities and long-term growth considerations.

The Company also announced the launch of its updated corporate website at http://www.jinmed.com, where the fireside chat will be webcast.

About Jin Medical International Ltd.

Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit the Company’s updated website at http://www.jinmed.com.

Forward-Looking Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may”, “will”, “should”, “intend”, “plan”, “strive”, “believe”, “expect”, “anticipate”, “project”, “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:
ir@jinmed.com